Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Assets (2016 - 2026)

Cumberland Pharmaceuticals' Current Assets history spans 16 years, with the latest figure at $37.1 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 1.67% to $37.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.1 million, a 1.67% increase, with the full-year FY2025 number at $37.1 million, up 1.67% from a year prior.
  • Current Assets hit $37.1 million in Q4 2025 for Cumberland Pharmaceuticals, up from $29.9 million in the prior quarter.
  • Over the last five years, Current Assets for CPIX hit a ceiling of $49.4 million in Q1 2021 and a floor of $29.9 million in Q3 2025.
  • Historically, Current Assets has averaged $40.6 million across 5 years, with a median of $42.7 million in 2023.
  • Biggest five-year swings in Current Assets: rose 10.39% in 2021 and later dropped 22.14% in 2023.
  • Tracing CPIX's Current Assets over 5 years: stood at $45.7 million in 2021, then grew by 0.4% to $45.9 million in 2022, then dropped by 22.14% to $35.7 million in 2023, then grew by 2.07% to $36.5 million in 2024, then rose by 1.67% to $37.1 million in 2025.
  • Business Quant data shows Current Assets for CPIX at $37.1 million in Q4 2025, $29.9 million in Q3 2025, and $31.2 million in Q2 2025.